Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Ранг среди акций #24698
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Цена акции
$0.95011029
Последняя синхронизация: 2023-06-28
Рыночная капитализация
$57.72M
Изменение (1 день)
8.53%
Изменение (1 год)
0.00%
Страна
FR
Торговля ERYTECH Pharma S.A. (ERYP)

Категория

История цены акций ERYTECH Pharma S.A. (ERYP)
Наивысшая цена закрытия: $0.90 2023-06-01

Наименьшая цена закрытия: $14.08 2013-05-01
История цены акций ERYTECH Pharma S.A. с 2013 по 2026
Годовая динамика цены акций
Год Результативность
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$552.00 38.88%
US
$1.05K 58.34%
NL
$152.13 480.21%
US
$118.70 -18.24%
AU
$769.41 9.73%
CH